Small-cap biotech Jaguar Health’s stock jumps 4% as it launches gelclair treatment for oral mucositis in cancer patients

By MarketWatch | Created at 2024-10-16 14:02:47 | Updated at 2024-10-16 16:27:04 2 hours ago

Please enable JS and disable any ad blocker